Mednax Graham Number from 2010 to 2026

MD Stock  USD 21.52  0.45  2.14%   
Mednax's Graham Number is decreasing over the years with slightly volatile fluctuation. Overall, Graham Number is expected to go to 16.27 this year. During the period from 2010 to 2026 Mednax Graham Number annual values regression line had geometric mean of  20.84 and mean square error of  217.43. View All Fundamentals
 
Graham Number  
First Reported
2010-12-31
Previous Quarter
12.52
Current Value
16.27
Quarterly Volatility
15.65978529
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Mednax financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mednax's main balance sheet or income statement drivers, such as Depreciation And Amortization of 29.8 M, Interest Expense of 25.2 M or Total Revenue of 1.5 B, as well as many indicators such as Price To Sales Ratio of 0.59, Dividend Yield of 0.0 or PTB Ratio of 1.56. Mednax financial statements analysis is a perfect complement when working with Mednax Valuation or Volatility modules.
  
Build AI portfolio with Mednax Stock
Check out the analysis of Mednax Correlation against competitors.
Analyzing Mednax's Graham Number over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Graham Number has evolved provides context for assessing Mednax's current valuation and future prospects.

Latest Mednax's Graham Number Growth Pattern

Below is the plot of the Graham Number of Mednax Inc over the last few years. It is Mednax's Graham Number historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mednax's overall financial position and show how it may be relating to other accounts over time.
Graham Number10 Years Trend
Slightly volatile
   Graham Number   
       Timeline  

Mednax Graham Number Regression Statistics

Arithmetic Mean27.27
Geometric Mean20.84
Coefficient Of Variation57.42
Mean Deviation13.84
Median18.81
Standard Deviation15.66
Sample Variance245.23
Range50.0152
R-Value(0.41)
Mean Square Error217.43
R-Squared0.17
Significance0.10
Slope(1.27)
Total Sum of Squares3,924

Mednax Graham Number History

2026 16.27
2025 12.52
2022 13.91
2019 18.81
2018 47.42
2017 50.87
2016 48.61

About Mednax Financial Statements

Mednax stakeholders use historical fundamental indicators, such as Mednax's Graham Number, to determine how well the company is positioned to perform in the future. Although Mednax investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mednax's assets and liabilities are reflected in the revenues and expenses on Mednax's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mednax Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Graham Number 12.52  16.27 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out the analysis of Mednax Correlation against competitors.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Will Health Care Providers & Services sector continue expanding? Could Mednax diversify its offerings? Factors like these will boost the valuation of Mednax. Expected growth trajectory for Mednax significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mednax data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
2.652
Earnings Share
1.91
Revenue Per Share
22.778
Quarterly Revenue Growth
(0.04)
Return On Assets
0.0686
Understanding Mednax Inc requires distinguishing between market price and book value, where the latter reflects Mednax's accounting equity. The concept of intrinsic value - what Mednax's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Mednax's price substantially above or below its fundamental value.
Understanding that Mednax's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mednax represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Mednax's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.